Status:

COMPLETED

Fatty Acid Amide Hydrolase (FAAH) Inhibitor Treatment of Cannabis Use Disorder (CUD)

Lead Sponsor:

Yale University

Collaborating Sponsors:

Columbia University

Johns Hopkins University

Conditions:

Cannabis Use Disorder

Eligibility:

All Genders

18-60 years

Phase:

PHASE2

Brief Summary

A Phase 2B, 8-Week, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy, Safety and Tolerability of the Fatty Acid Amide Hydrolase (FAAH) Inhibitor PF-04457845 ...

Detailed Description

The efficacy, safety and tolerability of the FAAH Inhibitor PF-0447845 in reducing cannabis use will be studied in a 4-site randomized, double-blind, placebo-controlled, parallel-group, outpatient cli...

Eligibility Criteria

Inclusion

  • Ages 18-60 years, inclusive.
  • Male or Female.
  • Individuals with DSM-V criteria for Cannabis Use Disorder .
  • Positive for urinary THC-COOH at both screening visits.
  • Must express a willingness at screening to set a date within the first week of randomization to attempt to quit using cannabis.

Exclusion

  • Clinically significant unstable medical disorders (as determined by the site investigator).
  • Laboratory tests with clinically significant abnormalities (as determined by the site investigator)
  • Pregnancy by history and or laboratory confirmation (serum HCG).
  • Lactation.
  • Physiological dependence on another substance.

Key Trial Info

Start Date :

January 14 2019

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

July 25 2022

Estimated Enrollment :

228 Patients enrolled

Trial Details

Trial ID

NCT03386487

Start Date

January 14 2019

End Date

July 25 2022

Last Update

February 14 2024

Active Locations (4)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (4 locations)

1

Connecticut Mental Health Center

New Haven, Connecticut, United States, 06519

2

Johns Hopkins University

Baltimore, Maryland, United States, 21224

3

Columbia University Medical College / New York State Psychiatric Institute

New York, New York, United States, 10032

4

Medical University of South Carolina

Charleston, South Carolina, United States, 29425